Skip to main content

levothyroxine

Generic: LEVOTHYROXINE SODIUM·Brand: ERMEZA, EUTHYROX, Ermeza, Euthyrox, LEVO-T, LEVOLET, LEVOTHYROXINE SODIUM, LEVOXYL, Levo-T, Levoxyl, SYNTHROID, Synthroid, THYQUIDITY, THYRO-TABS, TIROSINT, TIROSINT-SOL, Thyquidity, Thyro-Tabs, ThyroKare, Thyrocryn, Thyrolar, Tirosint, UNITHROID, Unithroid

levothyroxine: sourced relationships with 3 companies · 3 clinical trials tracked · 4 FDA decisions.

levothyroxine evidence translation

What we can confirm

4 FDA records · 3 tracked trials

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about levothyroxine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (4)
CompanyDated record stage
ANI PHARMACEUTICALS INC (ANIP)
Reported 2020-10-28 · Current development: unknownSource
Approved
MAIA Biotechnology, Inc. (MAIA)
Reported 2018-12-21 · Current development: unknownSource
Approved
MAIA Biotechnology, Inc. (MAIA)
Reported 2018-12-21 · Current development: unknownSource
Approved
DR REDDYS LABORATORIES LTD (RDY)
Reported 2020-03-27 · Current development: unknownSource
Approved
Clinical Trial Registry Records (3)

Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy

NCT06647602Registry updated 2026-02-10·N/A
Not yet recruiting

Primary endpoint: TSH after two weeks of TH substitution

Observational40 targetStarted 2026-09Completion 2028-122 sites · NetherlandsUniversity Medical Center Groningen

Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)

NCT05526144Registry updated 2026-02-19·Phase 2
Recruiting

Primary endpoint: Improvement in Nonalcoholic fatty liver disease activity score (NAS) by 2 points

InterventionalRandomizedtriple128 targetStarted 2023-04Completion 2029-121 site · United StatesVA Office of Research and Development

A Randomized, Double-blind, Dose-Conversion Study to Evaluate the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Subjects With Primary Hypothyroidism Who Are Euthyroid on Levothyroxine Replacement Therapy

NCT05712421Registry updated 2026-02-18·Phase 2
Completed

Primary endpoint: The ratio of the LT4 dose (mcg/day) at screening to North Star (mg/day) at the end of the treatment period required to achieve and maintain serum thyroid-stimulating hormone (TSH) levels within the normal reference range.

InterventionalRandomizedquadruple303 enrolledStarted 2023-02Completion 2025-0931 sites · United StatesNeuvosyn Laboratories, LLC
FDA Decisions4 records
Approval(ANIP)FDA ↗
ANDA213256UNKNOWNStandardOralCapsule
Approval(ANIP)FDA ↗
ANDA211369UNKNOWNStandardOralCapsule
Approval(RDY)FDA ↗
ANDA208837UNKNOWNStandardIntravenousPowder
Approval(MAIA)FDA ↗
ANDA208749UNKNOWNStandardIntravenousPowder

Frequently asked questions

Which companies have sourced relationships with levothyroxine?

levothyroxine has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC, MAIA Biotechnology, Inc., DR REDDYS LABORATORIES LTD.

How many clinical trials involve levothyroxine?

BioSniper tracks 3 clinical trials involving levothyroxine.

What is levothyroxine's latest FDA decision?

The most recent tracked FDA decision for levothyroxine is Approval, dated January 6, 2021.